The global ED drugs market consists of drugs indicated for the treatment of ED. These drugs include oral, topical, and other formulations, available both as prescription drugs and over-the-counter (OTC) drugs. Oral drugs were the first class of drugs that were developed for the treatment of ED. They hold a major share of the market because of their relative ease of administration. Topical drugs, sublingual, injectables, and suppositories, which have recently entered the market, hold small market shares.

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Software

7 Market Segmentation by Deployment

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape